Follow
Jessica Galloway-Pena
Title
Cited by
Cited by
Year
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, ...
Science 359 (6371), 97-103, 2018
38242018
Identification of bacteria-derived HLA-bound peptides in melanoma
S Kalaora, A Nagler, D Nejman, M Alon, C Barbolin, E Barnea, ...
Nature 592 (7852), 138-143, 2021
2212021
Complete genome sequence of Enterococcus faecium strain TX16 and comparative genomic analysis of Enterococcus faecium genomes
X Qin, JR Galloway-Peña, J Sillanpaa, JH Roh, SR Nallapareddy, ...
BMC microbiology 12, 1-20, 2012
1802012
Genomic and SNP analyses demonstrate a distant separation of the hospital and community-associated clades of Enterococcus faecium
J Galloway-Peña, JH Roh, M Latorre, X Qin, BE Murray
PloS one 7 (1), e30187, 2012
1722012
Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecium: a Prospective, Multicenter Study in South American Hospitals
D Panesso, J Reyes, S Rincón, L Díaz, J Galloway-Pena, J Zurita, ...
Journal of clinical microbiology 48 (5), 1562-1569, 2010
1442010
The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia
JR Galloway‐Peña, DP Smith, P Sahasrabhojane, NJ Ajami, ...
Cancer 122 (14), 2186-2196, 2016
1422016
Analysis of Clonality and Antibiotic Resistance among Early Clinical Isolates of Enterococcus faecium in the United States
JR Galloway-Peña, SR Nallapareddy, CA Arias, GM Eliopoulos, ...
The Journal of infectious diseases 200 (10), 1566-1573, 2009
1242009
Tools for analysis of the microbiome
J Galloway-Peña, B Hanson
Digestive diseases and sciences 65, 674-685, 2020
1142020
Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes
AR Flores, J Galloway-Peña, P Sahasrabhojane, M Saldaña, H Yao, X Su, ...
Proceedings of the National Academy of Sciences 112 (20), 6431-6436, 2015
962015
Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients
JR Galloway-Peña, DP Smith, P Sahasrabhojane, WD Wadsworth, ...
Genome medicine 9, 1-14, 2017
952017
Analysis of PBP5 of early US isolates of Enterococcus faecium: sequence variation alone does not explain increasing ampicillin resistance over time
JR Galloway-Pena, LB Rice, BE Murray
Antimicrobial agents and chemotherapy 55 (7), 3272-3277, 2011
932011
An integrative Bayesian Dirichlet-multinomial regression model for the analysis of taxonomic abundances in microbiome data
WD Wadsworth, R Argiento, M Guindani, J Galloway-Pena, SA Shelburne, ...
BMC bioinformatics 18, 1-12, 2017
902017
Gut microbiome signatures are predictive of infectious risk following induction therapy for acute myeloid leukemia
JR Galloway-Peña, Y Shi, CB Peterson, P Sahasrabhojane, ...
Clinical Infectious Diseases 71 (1), 63-71, 2020
712020
Impact of the microbiota on bacterial infections during cancer treatment
J Galloway-Peña, C Brumlow, S Shelburne
Trends in microbiology 25 (12), 992-1004, 2017
592017
Implementation of a pan-genomic approach to investigate holobiont-infecting microbe interaction: a case report of a leukemic patient with invasive mucormycosis
SA Shelburne, NJ Ajami, MC Chibucos, HC Beird, J Tarrand, ...
PLoS One 10 (11), e0139851, 2015
542015
Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease
E Hayase, T Hayase, MA Jamal, T Miyama, CC Chang, MR Ortega, ...
Cell 185 (20), 3705-3719. e14, 2022
402022
Fecal microbiome, metabolites, and stem cell transplant outcomes: a single-center pilot study
JR Galloway-Peña, CB Peterson, F Malik, PV Sahasrabhojane, DP Shah, ...
Open forum infectious diseases 6 (5), ofz173, 2019
392019
Can consideration of the microbiome improve antimicrobial utilization and treatment outcomes in the oncology patient?
JR Galloway-Peña, RR Jenq, SA Shelburne
Clinical Cancer Research 23 (13), 3263-3268, 2017
352017
Diversity of the fsr-gelE Region of the Enterococcus faecalis Genome but Conservation in Strains with Partial Deletions of the fsr Operon
JR Galloway-Pena, A Bourgogne, X Qin, BE Murray
Applied and environmental microbiology 77 (2), 442-451, 2011
352011
IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance …
WC Shropshire, SL Aitken, R Pifer, J Kim, MM Bhatti, X Li, A Kalia, ...
Journal of Antimicrobial Chemotherapy 76 (2), 385-395, 2021
342021
The system can't perform the operation now. Try again later.
Articles 1–20